Hvis man ikke kan undgå samtidig administration, kan forhøjede doser af Kaletra på 400 mg/ 400 mg to gange daglig administreres sammen med rifampicin
If this co-administration is judged unavoidable, increased dose of Kaletra at 400 mg/ 400 mg twice daily may be administered with rifampicin under close safety and therapeutic drug monitoring.